ANTIBACTERIAL AND ANTI-INFECTIVES (PART 2) Flashcards
etiologic agent of pulmonary TB
mycobacterium tuberculosis
most common site for the development of TB is the ___ (85% of patients)
lungs
most infectious TB patients
those with:
- cavitary pulmonary disease
- laryngeal TB
typical TB lesion
epithelioid granuloma with central caseastion necrosis
a cough of ___ weeks or more is already suspicious for PTB
2 weeks
symptoms of TB (along with cough)
- night sweats
- weight loss
- anorexia
- unexplained fever and chills
- chest pain
- fatigue
- body malaise
true or false: absence of fever excludes TB
false
true or false: physical findings are of little utility of PTB
true
what are the drugs used for TB?
RIPES
Rifampicin (R)
Isoniazid (H/INH)
Pyrazinamide (Z)
Ethambutol (E)
Streptomycin (S)
usual dose of isoniazid (H/INH)
5 mg/kg max 300 mg
usual dose of rifampicin (R)
10 mg/kg max 600 mg
usual dose of of pyrazinamide (Z)
25 mg/kg max 2 g (2000 mg)
usual dose of ethambutol (E)
15 mg/kg
usual dose of streptomycin (S)
15 mg/kg max 1 g (1000 mg)
- inhibits FATTY acid synthase and MYCOLIC acid synthesis
- excellent BACTERICIDAL activity against both intracellular and extracellular actively dividing MTB
- BACTERIOSTATIC against slowly dividing organisms
isoniazid (H/INH)
- binds to and inhibits mycobacterial DNA-dependent RNA polymerase = blocking RNA synthesis
- both intracellular and extracellular BACTERICIDAL activity, both in dividing and non-dividing MTB
rifampicin (R)
- has sterilizing activity
- most active antimycobacterial agents available and therefore cornerstone of FIRST-LINE TB treatment
rifampicin (R)
- exact mechanism is unclear but FATTY acid synthetase-I may be the primary target
- more active against SLOWLY replicating organisms than against actively replicating organisms
pyrazinamide (Z)
- active only in ACIDIC environment (pH < 6)
- found within phagocytes or granulomas
pyrazinamide (Z)
- inhibits ARABINOSYLTRANSFERASES involved in cell wall synthesis
- inhibits the formation of ARABINOGALACTAN and LIPOARABINOMANNAN
ethambutol (E)
- BACTERIOSTATIC antimycobacterial agents which provides synergy with other drugs
- LEAST potent against MTB
ethambutol (E)
- inhibits protein synthesis by binding at 30s mycobacterial ribosome
- BACTERICIDAL against dividing MTB but has only low-level early bactericidal activity
streptomycin (S)
what category?
- new PTB (bacteriologically or clinically diagnosed)
- new extra-PTB (bacteriologically or clinically diagnosed), except CNS/bones or joints
category I
what category?
- new extra-PTB (CNS/bones or joints)
category Ia
what category?
- pulmonary or E-PTB, previously treated drug-susceptible TB (bacteriologically or clinically diagnosed), except CNS/bones or joints
category II
what category?
- relapse
- treatment after failure
- treatment after lost to follow-up (TALF)
- previous treatment outcome unknown (PTOU)
category II
what category?
- E-PTB (CNS/bones or joints), previously treated, drug susceptible TB (bacteriologically or clinically diagnosed)
category IIa
what category?
- standard regimen drug-resistant (SRDR): rifampicin resistant TB or multi-drug resistant TB
- XDR TB regimen: extensively drug-resistant TB
drug resistant TB
alternative TB treatment regimen (initial and continuation) for:
category I
initial: 2 HRZE
cont: 4 HR / 4 HZE
alternative TB treatment regimen (initial and continuation) for:
category Ia
initial: 2 HRZE
cont: 10 HR
alternative TB treatment regimen (initial and continuation) for:
category II
initial: 2 HRZES and 1 HRZE
cont: 5 HRE
alternative TB treatment regimen (initial and continuation) for:
category IIa
initial: 2 HRZES and 1 HRZE
cont: 9 HRE
alternative TB treatment regimen (initial and continuation) for:
drug resistant TB
individualized based on prev. treatment and drug sensitivity
management for RIFAMPICIN caused GI intolerance
give medication at bed time
management for RIFAMPICIN caused orange-red urine
reassure patient
management for RIFAMPICIN caused flu-like symptoms
give anti-pyretics
management for PYRAZINAMIDE caused arthralgia due to hyperuricemia
give aspirin or NSAID
management for IZONIAZID caused burning sensation in feet (peripheral neuropathy)
give pyridoxine (vit b6) 100-200 mg daily; 10 mg daily for prevention
management for STREPTOMYCIN caused pain at injection site
warm compress
management for ANY DRUG caused mild skin reactions
give anti-histamines
which drug causes this MAJOR side effect?
- severe skin rash (hypersensitivity)
- jaundice due to hepatitis
any drug
which drug causes this MAJOR side effect?
- impairment for visual acuity and color vision due to optic neuritis
ethambutol (E)